{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
ESSA Pharma, Inc.
Is ESSA Pharma, Inc. technically bullish or bearish?
As of May 28, 2025, the market trend is mildly bearish, influenced by daily moving averages and mixed signals from weekly indicators, suggesting a cautious approach.
What does ESSA Pharma, Inc. do?
ESSA Pharma, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $6 million and a market cap of $75.02 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -25.10%.
How big is ESSA Pharma, Inc.?
As of Jun 18, ESSA Pharma, Inc. has a market capitalization of 75.02 million and reported net sales of 0.00 million with a net profit of -28.49 million for the latest four quarters. As of Sep 24, the company has shareholder's funds of 124.61 million and total assets of 128.11 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
